Inovalon

New Research From Inovalon and Harvard Analyzes Medicare Advantage Plan Design Impact on Healthcare Utilization and Health Equity

Retrieved on: 
Monday, April 8, 2024

The findings, published in the white paper " The Importance of Plan Design in Medicare Advantage ," represent the fourth installment of Inovalon’s and Harvard Medical School’s research collaboration to understand the underlying factors influencing enrollment, quality outcomes, and utilization in MA vs. FFS Medicare.

Key Points: 
  • The findings, published in the white paper " The Importance of Plan Design in Medicare Advantage ," represent the fourth installment of Inovalon’s and Harvard Medical School’s research collaboration to understand the underlying factors influencing enrollment, quality outcomes, and utilization in MA vs. FFS Medicare.
  • Previous research found that MA delivers superior quality outcomes and utilization reductions compared to FFS Medicare, even after controlling for differences in who enrolls.
  • However, until now, there was limited data on the differences within MA, and how specific MA plan designs and features impact outcomes.
  • "By understanding the populations Medicare Advantage plans attract, policymakers and health plans can come together to incentivize and deliver superior, cost-effective outcomes for every Medicare enrollee."

Inovalon's VigiLanz Solution Ranked No. 1 by KLAS Research in Pharmacy Surveillance and Infection Control and Monitoring

Retrieved on: 
Wednesday, February 21, 2024

1 in Pharmacy Surveillance, solidifying its position as the market leader in pharmacy surveillance software and bringing the company's total count of KLAS awards to 14.

Key Points: 
  • 1 in Pharmacy Surveillance, solidifying its position as the market leader in pharmacy surveillance software and bringing the company's total count of KLAS awards to 14.
  • "We are honored to be recognized as Best in KLAS for Pharmacy Surveillance for the seventh year in a row, and to be named the industry leader in Infection Control and Monitoring," said Dr. Hayley Burgess, SVP, Provider Surveillance and Safety at Inovalon.
  • VigiLanz Pharmacy Surveillance continuously monitors data from the EHR and ancillary clinical systems to improve medication safety, standardize practices, and maximize efficiencies.
  • Selected commentary collected about VigiLanz Infection Control and Monitoring and Pharmacy Surveillance, January 2024 © 2024 KLAS.

Palmetto Pharm Selects Inovalon ScriptMed® To Improve Patient Outcomes and Streamline Operations

Retrieved on: 
Monday, January 22, 2024

Inovalon’s ScriptMed Specialty will equip Palmetto Pharm with actionable insights to reduce administrative burden, foster improved collaboration between patients, providers, and health plans, and accelerate the time to therapies for enhanced clinical and financial outcomes.

Key Points: 
  • Inovalon’s ScriptMed Specialty will equip Palmetto Pharm with actionable insights to reduce administrative burden, foster improved collaboration between patients, providers, and health plans, and accelerate the time to therapies for enhanced clinical and financial outcomes.
  • Founded in 2022, Palmetto Pharm required a best-in-class cloud-based platform to scale efficiently and achieve its goal of becoming a nationwide specialty pharmacy licensed in all 50 states.
  • With their selection of the Inovalon pharmacy software platform solution, ScriptMed Specialty will now serve as the foundation for Palmetto Pharm’s customer-centric approach, which enables providers and patients to focus on managing their care for optimal outcomes.
  • Adopting best-in-class technology is just one way Palmetto Pharm goes the extra mile for patients and care teams, positioning them for continued success in the fast-growing specialty pharmacy market."

Clearsense Appoints Jason Rose as New Chief Executive Officer and Board Member

Retrieved on: 
Wednesday, January 24, 2024

JACKSONVILLE, Fla., Jan. 24, 2024 /PRNewswire/ -- Clearsense®, a Platform as a Service (PaaS) company that partners with healthcare organizations to increase data value, governance, and transparency, announced the appointment of Jason Z. Rose as the company's new Chief Executive Officer. Founder Gene Scheurer, who has served as the CEO of Clearsense since its inception in 2016, will remain on the Board of Directors, where he will serve as special advisor to the CEO. 

Key Points: 
  • Rose as the company's new Chief Executive Officer.
  • As a firm believer in the power of analytics in healthcare, timely and quality data can solve some of healthcare's most vexing challenges," said Rose.
  • Rose brings 30 years of healthcare technology experience and an extensive background leading, innovating, and scaling healthcare solutions, including several high-growth companies.
  • We consider ourselves fortunate to have him as our new chief executive."

Inovalon Applauded by Frost & Sullivan for Improving Healthcare Delivery, Patient Outcomes, and Data Security with Its Inovalon ONE® Platform

Retrieved on: 
Monday, December 11, 2023

SAN ANTONIO, Dec. 11, 2023 /PRNewswire/ -- Frost & Sullivan recently researched the healthcare analytics and real-world evidence (RWE) information technology solutions industry and, based on its analysis, recognizes Inovalon with the 2023 North American Product Leadership Award. The cloud-based software-as-a-service (SaaS) provider empowers healthcare organizations with data-driven insights to improve clinical, operational, and financial performance. Through the Inovalon ONE® Platform and its Insights solutions, Inovalon supports payers, providers, pharmacies, and life sciences organizations using real-world data (RWD) and advanced analytics to enhance healthcare outcomes and economics.

Key Points: 
  • Inovalon ONE® Platform seamlessly aggregates, standardizes, and analyzes diverse data to gain meaningful insights, support evidence-based decision-making, and offer data security and privacy.
  • Through the Inovalon ONE® Platform and its Insights solutions, Inovalon supports payers, providers, pharmacies, and life sciences organizations using real-world data (RWD) and advanced analytics to enhance healthcare outcomes and economics.
  • The cloud-based Inovalon ONE Platform provides SaaS solutions leveraging the company's national-scale connectivity, real-time primary source data, and advanced analytics to provide actionable insights that inform and expedite patient care and business strategies.
  • Using Inovalon's MORE2 Registry®, the nation's largest healthcare dataset originating from longitudinally matched and primary source data, the platform helps achieve data integration, compliance, and security.

Inovalon Applauded by Frost & Sullivan for Improving Healthcare Delivery, Patient Outcomes, and Data Security with Its Inovalon ONE® Platform

Retrieved on: 
Monday, December 11, 2023

SAN ANTONIO, Dec. 11, 2023 /PRNewswire/ -- Frost & Sullivan recently researched the healthcare analytics and real-world evidence (RWE) information technology solutions industry and, based on its analysis, recognizes Inovalon with the 2023 North American Product Leadership Award. The cloud-based software-as-a-service (SaaS) provider empowers healthcare organizations with data-driven insights to improve clinical, operational, and financial performance. Through the Inovalon ONE® Platform and its Insights solutions, Inovalon supports payers, providers, pharmacies, and life sciences organizations using real-world data (RWD) and advanced analytics to enhance healthcare outcomes and economics.

Key Points: 
  • Inovalon ONE® Platform seamlessly aggregates, standardizes, and analyzes diverse data to gain meaningful insights, support evidence-based decision-making, and offer data security and privacy.
  • Through the Inovalon ONE® Platform and its Insights solutions, Inovalon supports payers, providers, pharmacies, and life sciences organizations using real-world data (RWD) and advanced analytics to enhance healthcare outcomes and economics.
  • The cloud-based Inovalon ONE Platform provides SaaS solutions leveraging the company's national-scale connectivity, real-time primary source data, and advanced analytics to provide actionable insights that inform and expedite patient care and business strategies.
  • Using Inovalon's MORE2 Registry®, the nation's largest healthcare dataset originating from longitudinally matched and primary source data, the platform helps achieve data integration, compliance, and security.

NLP in Healthcare & Life Sciences Market worth $11.8 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, November 30, 2023

Text classification in NLP in Healthcare & Life Sciences Market categorizes medical data, organizing it into meaningful groups such as diagnoses, symptoms, or treatments.

Key Points: 
  • Text classification in NLP in Healthcare & Life Sciences Market categorizes medical data, organizing it into meaningful groups such as diagnoses, symptoms, or treatments.
  • This streamlined approach expedites diagnoses, treatments, and discoveries, serving as a catalyst for improved patient care and advancements in healthcare practices.
  • NLP solutions in Healthcare & Life sciences revolutionize data management, diagnosis, and patient interaction.
  • Top Key Companies in NLP in Healthcare & Life Sciences Market:
    In October 2023, Inovalon collaborated with AWS to develop AI/ML solutions for the healthcare industry.

NLP in Healthcare & Life Sciences Market worth $11.8 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, November 30, 2023

Text classification in NLP in Healthcare & Life Sciences Market categorizes medical data, organizing it into meaningful groups such as diagnoses, symptoms, or treatments.

Key Points: 
  • Text classification in NLP in Healthcare & Life Sciences Market categorizes medical data, organizing it into meaningful groups such as diagnoses, symptoms, or treatments.
  • This streamlined approach expedites diagnoses, treatments, and discoveries, serving as a catalyst for improved patient care and advancements in healthcare practices.
  • NLP solutions in Healthcare & Life sciences revolutionize data management, diagnosis, and patient interaction.
  • Top Key Companies in NLP in Healthcare & Life Sciences Market:
    In October 2023, Inovalon collaborated with AWS to develop AI/ML solutions for the healthcare industry.

Inovalon Expands Schedule Management SaaS Solution to Include Management of Third-Party Agency Staff

Retrieved on: 
Tuesday, November 7, 2023

Agency Management seamlessly integrates with Inovalon's Schedule Management , a cloud-based software solution offering a comprehensive workflow and analytics to effectively manage staff schedules, attendance, and credentials.

Key Points: 
  • Agency Management seamlessly integrates with Inovalon's Schedule Management , a cloud-based software solution offering a comprehensive workflow and analytics to effectively manage staff schedules, attendance, and credentials.
  • With Inovalon’s Agency Management SaaS solution, providers can more effectively manage staffing relationships with agencies.
  • Agency Management leverages intuitive technology to simplify the process of adding, removing, and maintaining agency organizations and individual employees for shifts.
  • Agency Management is fully interoperable with Schedule Management, a cloud-based pure SaaS solution built on the Inovalon ONE® Platform.

HiLabs Grows Product Delivery Leadership With Sumeet Seth and Harsh Vardhan

Retrieved on: 
Tuesday, November 7, 2023

BETHESDA, Md., Nov. 7, 2023 /PRNewswire/ -- HiLabs, maker of the healthcare data AI engine MCheck, announced it has added two leadership positions to its Product Delivery team. Sumeet Seth joins as SVP and Head of Product Delivery, along with Harsh Vardhan as VP of Product Delivery.  

Key Points: 
  • BETHESDA, Md., Nov. 7, 2023 /PRNewswire/ -- HiLabs, maker of the healthcare data AI engine MCheck, announced it has added two leadership positions to its Product Delivery team.
  • Sumeet Seth joins as SVP and Head of Product Delivery, along with Harsh Vardhan as VP of Product Delivery.
  • "I am delighted to welcome Sumeet and Harsh as HiLabs enters a period of rapid growth and ahead of new product innovations on the horizon.
  • Sumeet brings over 20 years of expertise in managing product strategy in technology-driven healthcare and finance firms to his new role at HiLabs.